Boston Scientific

Boston Scientific Attains Approval for Polymer Stent System

The medical device has received CE Mark approval for its Promus PREMIER coronary stent.

Boston Scientific Corporation has received CE Mark approval for the Promus PREMIER(TM) Everolimus-Eluting Platinum Chromium Coronary Stent System, the company's next-generation durable polymer drug-eluting stent (DES) technology, and is starting its European market launch. The Promus PREMIER Stent System is designed to provide physicians improved DES performance in treating patients with coronary artery disease.

No votes yet
Syndicate content